The microstructure evolution and strengthening mechanism of WE54 alloy with different hard-plate rolling(HPR)processes were systematically investigated.The results suggest that the mechanical properties of the as-roll...The microstructure evolution and strengthening mechanism of WE54 alloy with different hard-plate rolling(HPR)processes were systematically investigated.The results suggest that the mechanical properties of the as-rolled alloys are significantly enhanced compared to those of the as-cast alloy.When subjected to three rolling passes at 450℃ and 490℃,grain refinement occurs due to dynamic recrystallization.A mixed-grain structure is formed after a single pass rolling with a substantial reduction(65%)at 490℃.The dynamic recrystallization(DRX)mechanism of the alloy during the HPR includes continuous dynamic recrystallization(CDRX),discontinuous dynamic recrystallization(DDRX),and twin-induced recrystallization(TDRX).The WE54 alloy exhibits the highest strength after three passes of HPR at 450℃,with tensile strength and yield strength of 374 and 323 MPa,respectively.The significant improvement in the mechanical properties of the alloy is primarily attributed to fine-grain strengthening,solid solution strengthening,and dislocation strengthening.展开更多
BACKGROUND Over the years,the numbers of treatment options for colorectal cancer(CRC)have increased,leading to notable improvements in the overall survival of CRC patients.Although therapy may initially yield positive...BACKGROUND Over the years,the numbers of treatment options for colorectal cancer(CRC)have increased,leading to notable improvements in the overall survival of CRC patients.Although therapy may initially yield positive results,the development of drug resistance can result in treatment failure and cancer recurrence.This resistance is often attributed to the presence of cancer stem cells(CSCs).These CSCs not only contribute to therapeutic resistance but also play crucial roles in the initiation and development of tumor metastasis.AIM To investigate the antitumor effects of SH-4-54,which are mediated by targeting CSCs relative to treatment outcomes.METHODS CSCs were enriched by culturing CRC cells in serum-free medium.Hallmarks of stemness and IL-6/JAK2/STAT3 signaling were detected by Western blotting.Indicators of CSC malignancy,including proliferation,invasion,and tumor formation,were measured.RESULTS In this study,we employed SH-4-54,which exhibits anticancer activity in solid tumors through targeting the SH2 domain of both the signal transducer and activator of transcription(STAT)3 and the STAT5,and evaluated its effects on stemness and chemoresistance in colorectal CSCs.As expected,SH-4-54 treatment inhibited the phosphorylation of STAT3(p-STAT3)and decreased the percentage of ALDH1A1-positive CRC cells.The addition of SH-4-54 dissociated colorectal spheroids and decreased the expression of stemness markers,including ALDH1A1,CD44 and Nanog.SH-4-54 treatment decreased IL-6/JAK2/STAT3 signaling by inhibiting p-STAT3 and thus inhibited spheroid formation by SW480 and LoVo cells.Moreover,SH-4-54 treatment inhibited indicators of malignancy,including cell proliferation,invasion,and tumor formation,in CSCs in vitro and in vivo.Notably,SH-4-54 treatment significantly increased chemosensitivity to oxaplatin.CONCLUSION Taken together,these results indicate that SH-4-54 is a promising molecule that exerts antitumor effects on colorectal CSCs by inhibiting STAT3 signaling.展开更多
基金financially supported by the Natural Science Basic Research Program of Shaanxi Province,China(No.2023-JC-QN-0581)Advanced Power Specialty,China(No.YK22C-9)。
文摘The microstructure evolution and strengthening mechanism of WE54 alloy with different hard-plate rolling(HPR)processes were systematically investigated.The results suggest that the mechanical properties of the as-rolled alloys are significantly enhanced compared to those of the as-cast alloy.When subjected to three rolling passes at 450℃ and 490℃,grain refinement occurs due to dynamic recrystallization.A mixed-grain structure is formed after a single pass rolling with a substantial reduction(65%)at 490℃.The dynamic recrystallization(DRX)mechanism of the alloy during the HPR includes continuous dynamic recrystallization(CDRX),discontinuous dynamic recrystallization(DDRX),and twin-induced recrystallization(TDRX).The WE54 alloy exhibits the highest strength after three passes of HPR at 450℃,with tensile strength and yield strength of 374 and 323 MPa,respectively.The significant improvement in the mechanical properties of the alloy is primarily attributed to fine-grain strengthening,solid solution strengthening,and dislocation strengthening.
文摘BACKGROUND Over the years,the numbers of treatment options for colorectal cancer(CRC)have increased,leading to notable improvements in the overall survival of CRC patients.Although therapy may initially yield positive results,the development of drug resistance can result in treatment failure and cancer recurrence.This resistance is often attributed to the presence of cancer stem cells(CSCs).These CSCs not only contribute to therapeutic resistance but also play crucial roles in the initiation and development of tumor metastasis.AIM To investigate the antitumor effects of SH-4-54,which are mediated by targeting CSCs relative to treatment outcomes.METHODS CSCs were enriched by culturing CRC cells in serum-free medium.Hallmarks of stemness and IL-6/JAK2/STAT3 signaling were detected by Western blotting.Indicators of CSC malignancy,including proliferation,invasion,and tumor formation,were measured.RESULTS In this study,we employed SH-4-54,which exhibits anticancer activity in solid tumors through targeting the SH2 domain of both the signal transducer and activator of transcription(STAT)3 and the STAT5,and evaluated its effects on stemness and chemoresistance in colorectal CSCs.As expected,SH-4-54 treatment inhibited the phosphorylation of STAT3(p-STAT3)and decreased the percentage of ALDH1A1-positive CRC cells.The addition of SH-4-54 dissociated colorectal spheroids and decreased the expression of stemness markers,including ALDH1A1,CD44 and Nanog.SH-4-54 treatment decreased IL-6/JAK2/STAT3 signaling by inhibiting p-STAT3 and thus inhibited spheroid formation by SW480 and LoVo cells.Moreover,SH-4-54 treatment inhibited indicators of malignancy,including cell proliferation,invasion,and tumor formation,in CSCs in vitro and in vivo.Notably,SH-4-54 treatment significantly increased chemosensitivity to oxaplatin.CONCLUSION Taken together,these results indicate that SH-4-54 is a promising molecule that exerts antitumor effects on colorectal CSCs by inhibiting STAT3 signaling.
